<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is the third leading cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:hpo ids='HP_0011420'>death</z:hpo> in the world </plain></SENT>
<SENT sid="1" pm="."><plain>Human colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> is a complex, multistep and multigenetic process </plain></SENT>
<SENT sid="2" pm="."><plain>Cyclooxygenase-2 (COX2), a key enzyme in <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> metabolism, is overexpressed in several epithelial <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>COX2 expression can be induced by pro-inflammatory and mitogenic stimuli </plain></SENT>
<SENT sid="4" pm="."><plain>The -765G/C polymorphism of the COX2 gene promoter has been reported to affect <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> susceptibility, but recent studies have demonstrated conflicting results </plain></SENT>
<SENT sid="5" pm="."><plain>To shed light on these inconclusive findings, we performed a meta-analysis for assessing the involvement of COX2 -765G/C polymorphisms at the <z:hpo ids='HP_0003674'>onset</z:hpo> of colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Literature-based searching was guided to gather data and either fixed-effect or random-effect model was used to pool the odds ratio (OR) according to the test of <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The 10 eligible case-control studies included 3,322 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases and 5,166 controls </plain></SENT>
<SENT sid="8" pm="."><plain>Overall, no evidence has indicated that individuals carrying GC+CC genotypes had significantly increased <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk compared with GG genotype [OR = 1.06, 95% confidence interval (95% CI) = 0.94-1.20] </plain></SENT>
<SENT sid="9" pm="."><plain>However, stratified analysis with ethnicity indicated that individuals carrying GC+CC genotypes had an increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (OR = 1.40, 95% CI = 1.11-1.76) among Asian population </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, although not <z:hpo ids='HP_0000001'>all</z:hpo> bias could be eliminated, the -765C allele of the COX2 gene may be a potential risk factor for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in Asians </plain></SENT>
</text></document>